Rchr
J-GLOBAL ID：202101004106435307
Update date: Oct. 24, 2021
Shoii Satoshi
ショウジ サトシ | Shoii Satoshi
Affiliation and department：
Research field (1)：
Other
Research keywords (3)：
呼吸器
, 悪性腫瘍
, 肺癌
Papers (9)：
-
Yusuke Sato, Satoshi Watanabe, Takeshi Ota, Kohei Kushiro, Toshiya Fujisaki, Miho Takahashi, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, et al. Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease. Translational lung cancer research. 2021. 10. 7. 3132-3143
-
Satoshi Watanabe, Takeshi Ota, Masachika Hayashi, Hiroyuki Ishikawa, Aya Otsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Takao Miyabayashi, et al. Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy. Cancer medicine. 2020. 9. 9. 3070-3077
-
First-line osimertinib treatment in patients with lung squamous cell carcinoma harboring active epidermal growth factor receptor mutations. 2020
-
Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study. 2019
-
Yu Saida, Satoshi Watanabe, Tetsuya Abe, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Kenichi Koyama, Satoru Miura, Hiroshi Tanaka, et al. Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastases. Thoracic cancer. 2019. 10. 11. 2106-2116
ｍore...
Education (1)：
- 2012 - 2020 Niigata University Graduate School of Medicine
Work history (1)：
- 2017/04 - 現在 Niigata University Medical and Dental Hospital Respiratory Medicine and Infectious Disease teaching assistants
Return to Previous Page
